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The enzyme poly(ADP-ribosyl)transferase (ADPRT) becomes activated soon after a mitogenic stimulus i  applied to lym- 
phocyte cultures. It has also been reported that ADPRT inhibitors prevent cell proliferation when added to cultures at 
the same time as the mitogen. While this has been ascribed to the need to seal physiologically present DNA strand breaks 
before cells enter S phase, the presence of DNA strand breaks in quiescent human lymphocytes has been recently ques- 
tioned. We demonstrate h re that non-toxic oncentrations of ADPRT inhibitors do not affect lymphocyte blastization 
and proliferation, as measured by thymidine incorporation and cytofluorimetry. We therefore suggest that ADPRT acti- 
vation is required for late functions which are not needed for cell cycle progression. 
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1. INTRODUCTION 
The chromatin-bound enzyme poly(ADP- 
ribosyl)transferase (ADPRT; NAD + ADP-ribosyl- 
transferase, EC 2.4.2.30) catalyses the transfer of 
ADP-ribose units from NAD + to nuclear proteins, 
thus forming long, sometimes branched, ADP- 
ribose homopolymers (review [1]). Although the 
presence of DNA strand breaks (SB) appears to be 
a prerequisite for ADPRT activation, the role of 
the enzyme in DNA repair is still poorly under- 
stood [2-4]. Moreover, ADPRT activity has been 
found to increase with cell cycle progression 
[5-10]; this suggests that the enzyme also plays a 
role in physiological processes other than repair. 
In order to elucidate the function(s) of poly- 
(ADP-ribosyl)ation i both DNA repair and other 
physiological mechanisms, so-called specific 
ADPRT inhibitors [11] have been widely 
employed. ADPRT inhibitors have been reported 
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to prevent cell proliferation [5,12-14] when added 
at the onset of mitogen-stimulated lymphocyte 
cultures. So far, the presence of DNA SB has been 
generally accepted to be a prerequisite for ADPRT 
activation; therefore, research as been focused on 
searching for SB in quiescent lymphocytes. Recent- 
ly, Greer and Kaplan [15] concluded that a large 
amount of SB is endogenously present in mouse 
splenocytes, although they were unable to support 
the previously held view of the continuous forma- 
tion and sealing of such breaks [14,16]. At variance 
with this report, Boerrigter et al. [17] more recently 
failed to detect DNA SB in human peripheral lym- 
phocytes. These discrepancies, together with the 
consideration that past studies employed ADPRT 
inhibitor concentrations higher than those required 
for ADPRT inhibition and potentially capable of 
exerting side effects [18,19], prompted us to take a 
fresh look at the reported effect of ADPRT in- 
hibitors on lymphocyte proliferation. We 
demonstrate h re that ADPRT inhibition does not 
affect PHA-induced human lymphocyte blastiza- 
tion and proliferation. 
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2. MATERIALS  AND METHODS 
2.1. Lymphocyte proliferation 
Mononuclear blood cells from healthy volunteers were 
prepared as described [20], and cultured in nicotinamide-free 
RPMI 1640 medium (Gibco) supplemented with 10°70 heat- 
inactivated human pooled AB serum, 2 mM L-gtutamine, 
100 U/ml penicillin and 100/zg/ml streptomycin (latter 3 from 
Gibco). 3-Aminobenzamide (3ABA) and cell culture-tested 
nicotinamide (NAM) were purchased from Sigma, and 
3-methoxybenzamide from Aldrich; they were dissolved in 
RPMI 1640 medium on the day of the experiment. Cells were 
cultured in quadruplicate in 96-well tissue-culture microplates at
a concentration f 5 x 105/ml in the presence of1/zl/ml PHA-P 
(Wellcome). 0.1, 1, 5, or 10 mM 3ABA, 0.1, 1, 5, or 10 mM 
NAM, or 0.1, 1, or 2 mM 3MBA were added at the same time 
as PHA. Untreated and unstimulated untreated control cultures 
were also performed for every subject and each examined time 
of culture. Cultures were continued for 3, 4, 5, 6, or 7 days; 6 h 
before the end of the culture period, each well was pulsed with 
0.5/zCi tritiated thymidine ([3H]TdR, Amersham, spec. act. 
5 mCi/mmol). [aH]TdR incorporation was evaluated as in [20]. 
2.2. Cytofluorimetry 
Propidium iodide binding was performed according to [21]. 
Cells were fixed in 70070 ethanol for 30 min at 4°C, washed twice 
with cold PBS, incubated for 30 min at 37°C with RNase 
(40/~g/ml, Worthington), and then stained at room temperature 
for 1 h in a solution containing propidium iodide (18/zg/ml, 
Calbiochem). Before analysis, cells were passed several times 
through a 26 gauge needle to separate aggregates. Cytofluori- 
metry was performed by using a Facstar (Becton Dickinson), ex- 
ploying the 488 nm line from an argon ion laser. Cell cycle 
analysis was performed by the DNA cell-cycle analysis oftware 
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Fig. 1. Effect of 3ABA or NAM on PHA-induced lymphocyte 
proliferation. Cells were cultured as described for 3-7 days in 
the presence of 0.1 (o), 1 (*), 2 (©), 5 (N), or 10 (A) mM 
3ABA, NAM, or 3MBA. Data are means of 10 experiments, 
and are expressed as 070 [~H]TdR incorporation of untreated 
control cultures. SE did not exceed 10. 
When 3ABA or NAM was added at the same 
time as mitogen (fig. la,b),  [3H]TdR incorporat ion 
by PHA-st imulated lymphocytes was not 
significantly affected, except in 10 mM 3ABA- or 
NAM-treated cultures, where [3H]TdR incorpora- 
t ion was initially reduced by 42-40°7o. At days 6 
and 7, addit ion of 10 mM 3ABA caused an 
enhancement in [3H]TdR incorporat ion, which 
often resulted in absolute values higher than those 
obtained in control cultures of the same subject on 
the day of peak [3H]TdR incorporat ion (day 3 or 
4). 
Fig . lc  shows the effects of 3MBA. It should be 
noted that the concentrat ion of 2 mM, which ap- 
pears to inhibit DNA synthesis, is probably cyto- 
toxic. The two lower concentrations had no effect 
on [3H]TdR uptake. 
In one experiment, 3ABA was prepared from a 
stock solution made containing ethanol. We found 
that both 2.5% ethanol alone and 5 mM 3ABA 
dissolved in 2.5% ethanol inhibited [3H]TdR incor- 
porat ion (fig.2). 
In order to obtain independent determination f 
the effect of ADPRT inhibitors on lymphocyte 
prol i feration and to evaluate other parameters of 
PHA- induced lymphocyte blastization, including. 
early events uch as the increase in cell size [22,23], 
cytofluorimetric measures were sought. Fig.3 
shows that the cell size, cell density, and DNA con- 
tent of cells which received 5 mM 3ABA at the 
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Fig.2. Effect of ethanol on PHA-induced lymphocyte prolifera- 
tion. Cells were cultured as described for 3-5 days in the 
presence of 5 mM 3ABA (m) dissolved in culture medium, 2.5070 
ethanol (©), or 5 mM 3ABA dissolved in 2.5070 ethanol (n). 
Data from one representative experiment are shown as °70 
[3H]TdR incorporation of untreated control cultures. 
onset of the cultures were the same as those of un- 
treated controls at all the examined times. Cell cy- 
cle analysis howed that the percentage of cycling 
cells was not affected by the presence of 3ABA. 
Three different subjects were analysed, with nearly 
identical results. 
4. DISCUSSION 
Our data partially contrast with those reported 
by others: (i) it has been reported that addition of 
3MBA at the onset of lymphocyte cultures inhibits 
subsequent [3H]TdR incorporation only at concen- 
trations above 1 mM [15,24]; (ii) the effects of 
NAM were also described as being somewhat 
concentration-dependent: 0.1-0.5 mM NAM was 
found to enhance DNA synthesis [5], 2 mM being 
neutral [23], and 5-10 mM inhibitory [5,13,25]; 
(iii) at 5 mM, 3ABA was found to inhibit lympho- 
cyte proliferation [12,13,15], but others observed 
that, within the range 0.5-2.0 mM, mouse thymus 
T-lymphocytes were stimulated [26]. In our hands, 
[3H]TdR incorporation is not greatly affected by 
0.1-1 mM 3MBA or 0.1-5 mM 3ABA or NAM. 
The higher concentrations appear to be initially in- 
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S 1 9 7 29 30 
G2/M 0 3 2 5 3 
Fig.3. Cell size (FSC, first row), cell density (SSC, second row), DNA content (FL2, third row), and percent of cells in Go~G1, S, or 
G JM (bottom), as analysed by a Facstar cytofluorimeter and DNA cell-cycle analysis oftware in lymphocytes cultured in the absence 
or presence of 5 mM 3ABA, as described in the text. 
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hibitory and in particular 10 mM 3ABA seems to 
alter the kinetics of lymphocyte proliferation. A 
delay in cell cycle progression due to the addition 
of 10 mM 3ABA has also been described as occurr- 
ing in CHO cells [27]. Overall, however, our data 
are not indicative of inhibition of cell proliferation 
due to the initial addition of ADPRT inhibitors. 
As pointed out by Cleaver et al. [18], little is 
known about the effective concentrations of 
ADPRT inhibitors in intact ceils as opposed to 
permeable ones. Kun et al. [28] observed that, in 
intact fibroblasts, 1 mM 3ABA in the culture 
medium resulted in a concentration of 10/zM in- 
side the cell, which apparently increased, rather 
than inhibited, ADPRT activity. Furthermore, 
very little is known about the rate at which benz- 
amides and nicotinamide are metabolized in intact 
cells, i.e. concerning the concentration eventually 
reached at the time when DNA synthesis actually 
takes place. On the other hand, high benzamide 
concentrations are likely to have pleiotropic, and 
even toxic, side effects [19,29,30]. This uncertainty 
is even greater for NAM, since it is both a precur- 
sor of NAD +, the ADPRT substrate, and an in- 
hibitor of ADPRT activity. Therefore, both NAM 
starvation and addition have been used to inhibit 
the enzyme activity [31]. 
It may be added that in the past ethanol was 
widely used as a solvent for benzamide solutions 
[14]. It has been demonstrated that trace amounts 
of ethanol induce DNA SB in cultured lymphoid 
cells [29] and alter poly(ADP-ribose) metabolism 
[32]. We have obtained evidence suggesting that 
the presence of ethanol inhibits [3H]TdR uptake in 
lymphocytes. 
We approached these methodological problems 
via a carefully planned protocol: (i) three ADPRT 
inhibitors (3ABA, 3MBA, NAM) were used (NAM 
is considered to exert its inhibition in a different 
way vs benzamides); (ii) solutions were prepared in 
culture medium; (iii) a wide range of concentra- 
tions was tested, which is likely to comprise the in- 
hibitory dose in intact cells, and higher concentra- 
tions were avoided in order to minimize both tox- 
icity and side effects; :(iv) cultures were continued 
for 7 days, in order to observe the entire course of 
the kinetics of the PHA-induced proliferative 
response; (v) in order to avoid possible variability 
among lymphocytes from different subjects, 
[3H]TdR incorporation was studied in 10 different 
subjects; (vi) the effect of ADPRT inhibitors on 
lymphocyte proliferation was evaluated by two in- 
dependent experimental systems. 
Therefore, on the basis of this complete ex- 
perimental protocol, we conclude that ADPRT in- 
hibition does not prevent PHA-induced lympho- 
cyte blastization and proliferation. This finding is 
in accordance with the observation that there are 
no DNA SB, requiring the intervention of 
ADPRT-related repair mechanisms, in quiescent 
lymphocytes [17]. ADPRT is induced at an early 
stage during mitogen-stimulated lymphocyte 
cultures [10], however its activity reaches max- 
imum at around the 48-72 h [6,8]; this observation 
also supports the view that ADPRT is not required 
for early DNA repair. It has been suggested that 
ADPRT carries out other functions, probably 
related to specific changes in the chromatin struc- 
ture [33-35]. Therefore; ADPRT expression may 
very well be cell cycle-regulated, rather than cell 
cycle-regulative, in the same way as other genes are 
[36]. 
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